• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Managing Fatigue During Breast Cancer Treatment: Tips for Conserving Energy

by MM360 Staff | May 1, 2025 | Uncategorized

Source: CureToday articles Breast cancer treatment is a physical, emotional, and mental challenge. Facing cancer and its side effects demands extraordinary physical, emotional, and spiritual stamina. Read More

Triage Health Conference: Free Education to Navigate Health Care

by MM360 Staff | May 1, 2025 | Uncategorized

Source: CureToday articles Triage Health offers free, expert-led education on the legal and practical issues that impact individuals coping with chronic or serious medical conditions. Read More

Advances in surgical techniques and targeted therapies for Pancreatic Cancer

by MM360 Staff | May 1, 2025 | Uncategorized

Source: CureToday articles Pancreatic cancer is one of the most challenging cancers to treat. Read More

The Impact of Breast Cancer on Self-Image

by MM360 Staff | May 1, 2025 | Uncategorized

Source: CureToday articles A breast cancer diagnosis brings about many losses. Read More

Breaking Down the Stigma and How to Better Understand Rare Blood Cancers

by MM360 Staff | May 1, 2025 | Uncategorized

Source: CureToday articles Dr. Neha Mehta-Shah discusses ways patients with rare blood cancers, such as lymphoma, can better understand their specific subtype of disease. Read More

Endoscopic Procedure Removes GIST Without Surgery

by MM360 Staff | May 1, 2025 | Uncategorized

Source: CureToday articles A new endoscopic tunneling method, STER, allowed a patient to have a GIST removed without surgery, allowing quicker recovery and fewer complications. Read More
« Older Entries
Next Entries »

Recent Content

  • (no title)
  • New center promotes advocacy for gynecological cancer patients
  • FDA clears Thermo Fisher EXTENT system for myeloma diagnosis
  • Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma
  • TSCM-predominant allogeneic anti-BCMA CAR-T therapy for relapsed/refractory multiple myeloma: preclinical characterization and interim results from a phase 1 trial
  • (no title)
  • (no title)
  • New ‘powerful’ lab test will help researchers explore blood cancer
  • Assessing the correlation between patient and family reported outcome measures and multiple myeloma clinical parameters
  • Defining the proteome of bone marrow plasma in multiple myeloma and monoclonal gammopathy of undetermined significance
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT